Point72 Asset Management »

Dianthus Therapeutics shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Dianthus Therapeutics (DNTH) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Dianthus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dianthus Therapeutics held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dianthus Therapeutics by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 352k 30.00

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)
Broadcom (AVGO)
At&t (T)
Microsoft Corporation (MSFT)
Fox Corp Cl A Com (FOXA)
FedEx Corporation (FDX)
Arista Networks (ANET)
Coca-Cola Company (KO)
Paypal Holdings (PYPL)
Edwards Lifesciences (EW)
Boeing Company (BA)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)

View all positions for Point72 Asset Management

Top funds holding Dianthus Therapeutics

FMR
Bain Capital Life Sciences Investors
Fairmount Funds Management
Avidity Partners Management
RA Capital Management
VR Adviser
Octagon Capital Advisors
5AM Venture Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Henderson Group
Point72 Asset Management
Adage Capital Partners GP
Millennium Management
Tang Capital Management

View all funds holding Dianthus Therapeutics